Cocoa futures have plunged to multi-year lows, pressured by a global surplus and weakening demand as high chocolate prices curb consumption. Analysts point to favorable harvests in West Africa and falling processing volumes as key factors extending the market's month-long decline.
Sciwind Biosciences secures Chinese approval for its GLP-1 agonist Xianyida, entering a crowded but high-stakes diabetes treatment market dominated by global giants, as the country grapples with the world's largest diabetic population.
A surge of competitively priced Chinese electric vehicles and consumer goods is rapidly transforming Latin American markets, forcing governments from Mexico to Brazil to enact new tariffs and trade defenses to shield domestic industries from the influx.
As Chinese exports, from electric vehicles to e-commerce parcels, flood Latin American markets, governments are walking a tightrope between protecting domestic industries and satisfying consumer demand for affordable goods, all while navigating deepening economic ties with Beijing.
As China's pork industry grapples with overcapacity and falling prices, a growing appetite for premium, flavorful black pork among the middle class is offering a lifeline to farmers and reshaping market strategies.
The consumer goods giant reports resilient Q4 2025 results, beating expectations despite market headwinds, and unveils a comprehensive new strategy focused on omnichannel demand, premiumization, and AI-driven efficiency to drive growth through 2030.
Following the UK Prime Minister's visit to Beijing, China has agreed to slash tariffs on UK-produced whiskies from 10% to 5%, a move welcomed by the industry as a potential catalyst for growth in a key premium market.
While Morgan Stanley maintains an Overweight rating on PDD Holdings, the firm has removed the e-commerce giant from its Top Picks list, citing heightened regulatory scrutiny and a slower-than-expected consumer recovery in China.
Shares of Yum China Holdings (NYSE:YUMC) have climbed steadily over recent months, reigniting investor interest in the fast-food giant's fundamentals and valuation story. With the stock trading below a key fair value estimate, analysts are weighing the sustainability of its momentum against rising operational headwinds in the Chinese market.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
Sonos (SONO) is set to report its fiscal fourth-quarter earnings after Tuesday's market close. Investors are watching closely to see if the audio specialist can maintain its track record of outperformance in a challenging consumer spending environment.
While consumer staples are traditionally seen as safe havens, recent underperformance against the broader market has spotlighted companies with weakening fundamentals. We examine three household names where valuation and growth concerns suggest caution is warranted.
While the consumer staples sector has lagged the broader market rally, select companies continue to demonstrate defensive strength and growth potential. We analyze one standout and two stocks facing significant headwinds.
Amid a volatile economic backdrop, consumer discretionary stocks are lagging the broader market. We examine three companies—Columbia Sportswear, Movado, and iHeartMedia—whose business models and valuations make them vulnerable in the current climate.
As gold prices soar past $5,400 an ounce before a sharp pullback, a global rush is underway. From Parisian boutiques to Main Street dealers, consumers are capitalizing on heirlooms or diving into the market, driven by geopolitical tensions and economic uncertainty.
Historical data reveals a counterintuitive trend: periods of extreme pessimism in consumer sentiment have often preceded strong stock market gains, aligning with Warren Buffett's famed contrarian advice.
CNBC's Jim Cramer offers a detailed take on NVIDIA's stock trajectory, highlighting analyst optimism around its data center partnerships while expressing skepticism over reported Chinese AI chip purchases.
Freedom Capital Markets has lowered its price target for Li Auto (NASDAQ: LI) from $34 to $25, citing a mixed quarterly performance and a challenging outlook as China's electric vehicle sector grapples with a fierce price war and softening demand.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
After a prolonged period of U.S. dominance, international equities are staging a comeback. Analysts point to shifting fundamentals, attractive valuations, and a weakening dollar as tailwinds for emerging markets, with one Vanguard ETF positioned at the center of this transition.
